658 related articles for article (PubMed ID: 10440091)
1. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
2. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
3. Effects of supraspinal administration of PG-SPI and PG-KII, two amphibian tachykinin peptides, on nociception in the rat.
Improta G; Broccardo M
Peptides; 2000 Nov; 21(11):1611-6. PubMed ID: 11090914
[TBL] [Abstract][Full Text] [Related]
4. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
5. Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors.
Polidori C; Panocka I; Ciccocioppo R; Broccardo M; Improta G; Regoli D; Massi M
Peptides; 1997; 18(6):825-33. PubMed ID: 9285931
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
7. Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig.
Linari G; Broccardo M; Nucerito V; Improta G
Peptides; 2002 May; 23(5):947-53. PubMed ID: 12084527
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences.
Linari G; Improta G; Agostini S; Andreassi A; Broccardo M
Peptides; 2004 Jan; 25(1):45-51. PubMed ID: 15003355
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
10. Tachykinins and central respiratory activity: an in vitro study on the newborn rat.
Monteau R; Ptak K; Broquère N; Hilaire G
Eur J Pharmacol; 1996 Oct; 314(1-2):41-50. PubMed ID: 8957217
[TBL] [Abstract][Full Text] [Related]
11. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle.
Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L
Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices.
Seabrook GR; Bowery BJ; Hill RG
Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo biological activities of PG-KII, a novel kassinin-like peptide from the skin of the Australian frog, Pseudophryne güntheri.
Improta G; Broccardo M; Severini C; Erspamer V
Peptides; 1996; 17(6):1003-8. PubMed ID: 8899820
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for the involvement of tachykinin NK3 receptors in the hexamethonium-resistant inhibitory transmission in the rat colon.
Lecci A; Giuliani S; Tramontana M; Meini S; De Giorgio R; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):671-9. PubMed ID: 8738300
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
17. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
18. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon.
Maggi CA; Zagorodnyuk V; Giuliani S
Regul Pept; 1994 Oct; 53(3):259-74. PubMed ID: 7531357
[TBL] [Abstract][Full Text] [Related]
20. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):512-9. PubMed ID: 8751080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
